LSA
PFE icon

L & S Advisors’s Pfizer PFE Stock Holding History

L & S Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,879
Closed -$395K – 257
2025
Q4 		$395K Buy
+15,879
New +$400K 0.04% 287
2022
Q2 		– Sell
-97,736
Closed -$5.06M – 284
2022
Q1 		$5.06M Sell
97,736
-45,365
-32% -$2.35M 0.6% 59
2021
Q4 		$8.45M Buy
143,101
+130,286
+1,017% +$6.46M 0.91% 27
2021
Q3 		$551K Buy
+12,815
New +$568K 0.06% 235
2020
Q4 		– Sell
-140,628
Closed -$4.9M – 356
2020
Q3 		$4.9M Buy
+140,628
New +$4.93M 0.67% 43
2019
Q1 		– Sell
-162,096
Closed -$6.71M – 336
2018
Q4 		$6.71M Sell
162,096
-674
-0.4% -$28K 1.26% 19
2018
Q3 		$6.81M Buy
+162,770
New +$6.27M 0.88% 34
2017
Q2 		– Sell
-8,558
Closed -$278K – 305
2017
Q1 		$278K Buy
+8,558
New +$270K 0.05% 197
2016
Q4 		– Sell
-104,947
Closed -$3.37M – 181
2016
Q3 		$3.37M Sell
104,947
-140,130
-57% -$4.69M 0.93% 39
2016
Q2 		$8.19M Buy
+245,077
New +$7.82M 1.86% 9
2016
Q1 		– Sell
-170,624
Closed -$5.23M – 96
2015
Q4 		$5.23M Buy
170,624
+69,554
+69% +$2.19M 1.31% 28
2015
Q3 		$3.01M Buy
101,070
+11,887
+13% +$381K 0.88% 50
2015
Q2 		$2.84M Buy
89,183
+11,319
+15% +$369K 0.72% 50
2015
Q1 		$2.57M Buy
77,864
+28,042
+56% +$892K 0.68% 50
2014
Q4 		$1.47M Buy
49,822
+23,220
+87% +$666K 0.46% 51
2014
Q3 		$746K Buy
26,602
+6,135
+30% +$172K 0.37% 30
2014
Q2 		$576K Sell
20,467
-131,010
-86% -$3.73M 0.23% 57
2014
Q1 		$4.62M Buy
+151,477
New +$4.52M 2.46% 6
2013
Q4 		– Sell
-16,966
Closed -$462K – 107
2013
Q3 		$462K Sell
16,966
-388
-2% -$10.6K 0.19% 55
2013
Q2 		$461K Buy
+17,354
New +$479K 0.23% 49

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

L & S Advisors's PFE Position: Q1 2026 in Review

L & S Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 15,879 shares — an estimated $395K sold.

L & S Advisors first reported a position in PFE in Q2 2013 and held it in 20 quarters. The position peaked at $8.45M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • L & S Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • L & S Advisors sold 15,879 Pfizer shares in Q1 2026, an estimated $395K.
  • L & S Advisors first reported a position in Pfizer in Q2 2013 and held it in 20 quarters.
  • L & S Advisors's Pfizer position peaked at $8.45M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on L & S Advisors's 13F filing for Q1 2026, filed 11 May 2026.